Gilead Sciences' COVID-19 Treatment Earns Conditional Approval in Europe

Motley Fool

03 Jul 2020 0 shares 1 views

Gilead Sciences' COVID-19 Treatment Earns Conditional Approval in Europe

Gilead Sciences' COVID-19 Treatment Earns Conditional Approval in Europe

Motley Fool

Published 03 Jul 2020

The European Commission has granted conditional approval to Veklury, the antiviral known as remdesivir.

You might like

Related news coverage

FTSE 100 wallows in the red; travel sector under renewed pressure after UK imposes quarantine on travellers from Spain
Proactive Investors 27 Jul 2020
NA Proactive news snapshot: Chemesis International, Gatling Exploration, 1933 Industries, Genprex, NexTech AR UPDATE ...
Proactive Investors 22 Jul 2020

NA Proactive news snapshot: Gatling Exploration, 1933 Industries, Genprex, NexTech AR UPDATE ...
Proactive Investors 22 Jul 2020
NA Proactive news snapshot: Mota Ventures, Benchmark Metals, QBioMed, Pure Gold Mining …
Proactive Investors 22 Jul 2020

Advertisement